510 related articles for article (PubMed ID: 34359886)
21. Role of miR-145 in cardiac myofibroblast differentiation.
Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.
Tarbit E; Singh I; Peart JN; Rose'Meyer RB
Heart Fail Rev; 2019 Jan; 24(1):1-15. PubMed ID: 29987445
[TBL] [Abstract][Full Text] [Related]
23. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
25. Cellular players in lung fibrosis.
Lekkerkerker AN; Aarbiou J; van Es T; Janssen RA
Curr Pharm Des; 2012; 18(27):4093-102. PubMed ID: 22630084
[TBL] [Abstract][Full Text] [Related]
26. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
Dobaczewski M; de Haan JJ; Frangogiannis NG
J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice.
Maity S; Muhamed J; Sarikhani M; Kumar S; Ahamed F; Spurthi KM; Ravi V; Jain A; Khan D; Arathi BP; Desingu PA; Sundaresan NR
J Biol Chem; 2020 Jan; 295(2):415-434. PubMed ID: 31744885
[TBL] [Abstract][Full Text] [Related]
29. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.
Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C
Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869
[TBL] [Abstract][Full Text] [Related]
30. Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibroblasts-to-Myofibroblasts Trans-Differentiation.
Li C; Lin T; Li D; Si D; Sun H; Yang S; Zhang Z; Zhang Q; Shi K
Anatol J Cardiol; 2023 Jul; 27(7):398-407. PubMed ID: 37288854
[TBL] [Abstract][Full Text] [Related]
31. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices.
Galie PA; Westfall MV; Stegemann JP
Cardiovasc Pathol; 2011; 20(6):325-33. PubMed ID: 21306921
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
33. Role of Cardiac Fibroblasts in Cardiac Injury and Repair.
Han M; Zhou B
Curr Cardiol Rep; 2022 Mar; 24(3):295-304. PubMed ID: 35028821
[TBL] [Abstract][Full Text] [Related]
34. Infarct Collagen Topography Regulates Fibroblast Fate via p38-Yes-Associated Protein Transcriptional Enhanced Associate Domain Signals.
Bugg D; Bretherton R; Kim P; Olszewski E; Nagle A; Schumacher AE; Chu N; Gunaje J; DeForest CA; Stevens K; Kim DH; Davis J
Circ Res; 2020 Oct; 127(10):1306-1322. PubMed ID: 32883176
[TBL] [Abstract][Full Text] [Related]
35. Are Interactions between Epicardial Adipose Tissue, Cardiac Fibroblasts and Cardiac Myocytes Instrumental in Atrial Fibrosis and Atrial Fibrillation?
Krishnan A; Chilton E; Raman J; Saxena P; McFarlane C; Trollope AF; Kinobe R; Chilton L
Cells; 2021 Sep; 10(9):. PubMed ID: 34572150
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
[TBL] [Abstract][Full Text] [Related]
37. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
38. The origin and arrhythmogenic potential of fibroblasts in cardiac disease.
Vasquez C; Morley GE
J Cardiovasc Transl Res; 2012 Dec; 5(6):760-7. PubMed ID: 22987310
[TBL] [Abstract][Full Text] [Related]
39. Mechanical regulation of myofibroblast phenoconversion and collagen contraction.
Hinz B; McCulloch CA; Coelho NM
Exp Cell Res; 2019 Jun; 379(1):119-128. PubMed ID: 30910400
[TBL] [Abstract][Full Text] [Related]
40. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.
Liu M; López de Juan Abad B; Cheng K
Adv Drug Deliv Rev; 2021 Jun; 173():504-519. PubMed ID: 33831476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
